Ovidrel (EMD Serono, Inc.)
Welcome to the PulseAid listing for the Ovidrel drug offered from EMD Serono, Inc.. This Gonadotropin [EPC],Gonadotropins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | EMD Serono, Inc. |
NON-PROPRIETARY NAME: | choriogonadotropin alfa |
SUBSTANCE NAME: | CHORIOGONADOTROPIN ALFA |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Gonadotropin [EPC],Gonadotropins [Chemical/Ingredient] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2003-10-06 |
END MARKETING DATE: | 0000-00-00 |
Ovidrel HUMAN PRESCRIPTION DRUG Details:
Item Description | Ovidrel from EMD Serono, Inc. |
LABELER NAME: | EMD Serono, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(ug/.5mL) |
START MARKETING DATE: | 2003-10-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 44087-1150_aa66e33f-3db4-4658-b31f-aef336eca26d |
PRODUCT NDC: | 44087-1150 |
APPLICATION NUMBER: | NDA021149 |
Other CHORIOGONADOTROPIN ALFA Pharmaceutical Manufacturers / Labelers: